FDA Approved: MVASI — Original Application (Amgen, Inc)

View source ↗

Summary

The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for this bevacizumab bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Glioblastoma
• Non-small Cell Lung Cancer
• Peritoneal Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Mvasi (Bevacizumab)

Snippet

ORIG AP for MVASI (BEVACIZUMAB-AWWB)